We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
+1.38%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$23.9B
AUM Growth
-$469M
(-1.9%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
1,935
New
209
Increased
532
Reduced
683
Closed
293
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$392M |
| 2 |
BP
BP
|
+$158M |
| 3 |
General Motors
GM
|
+$152M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$148M |
| 5 |
Amdocs
DOX
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$102M |
| 2 |
Marriott International
MAR
|
+$95.6M |
| 3 |
Fortinet
FTNT
|
+$94.9M |
| 4 |
Cardinal Health
CAH
|
+$91.3M |
| 5 |
Apple
AAPL
|
+$88.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.31% |
| 2 | Consumer Discretionary | 13.19% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Staples | 10.22% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
BioNTech
BNTX
$23.3B
| $12.6M | 0.05% |
116,071
-25,095
| -18% | -$2.78M |
|
252
AGCO
AGCO
$7.06B
| $12.6M | 0.05% |
106,552
-103,805
| -49% | -$13.2M |
|
253
Cellebrite
CLBT
$3.97B
| $12.6M | 0.05% |
1,646,480
+1,230,244
| +296% | +$9.23M |
|
254
Medpace
MEDP
$16.8B
| $12.6M | 0.05% |
51,928
-23,839
| -31% | -$6.1M |
|
255
Worthington Enterprises
WOR
$2.79B
| $12.6M | 0.05% |
329,751
+217,502
| +194% | +$9.56M |
|
256
Gaotu Techedu
GOTU
$444M
| $12.2M | 0.05% |
4,445,239
+625,976
| +16% | +$1.96M |
|
257
Cirrus Logic
CRUS
$6.11B
| $12.2M | 0.05% |
165,556
+1,712
| +1% | +$134K |
|
258
Deutsche Bank
DB
$71.9B
| $12.2M | 0.05% |
1,100,738
+313,135
| +40% | +$3.39M |
|
|
DRD
259
DRDGold
DRD
$2.05B
| $12.2M | 0.05% |
1,467,309
+93,250
| +7% | +$941K |
|
260
Verisk Analytics
VRSK
$23.6B
| $12.1M | 0.05% |
51,131
+50,705
| +11,903% | +$12M |
|
261
Synchrony
SYF
$25.4B
| $12M | 0.05% |
393,933
-47,630
| -11% | -$1.59M |
|
262
Covenant Logistics
CVLG
$843M
| $12M | 0.05% |
548,224
-98,280
| -15% | -$2.38M |
|
263
Macy's
M
$6.55B
| $11.9M | 0.05% |
1,026,225
+489,178
| +91% | +$6.85M |
|
264
Prologis
PLD
$132B
| $11.9M | 0.05% |
105,703
+34,325
| +48% | +$4.2M |
|
|
FINV
265
FinVolution Group
FINV
$1.11B
| $11.8M | 0.05% |
2,363,652
+1,559,522
| +194% | +$8.16M |
|
266
Plains All American Pipeline
PAA
$16.4B
| $11.6M | 0.05% |
759,627
+678,585
| +837% | +$10.2M |
|
267
O'Reilly Automotive
ORLY
$75.3B
| $11.5M | 0.05% |
189,210
-13,605
| -7% | -$853K |
|
|
MDC
268
DELISTED
M.D.C. Holdings, Inc.
MDC
| $11.4M | 0.05% |
277,304
-87,057
| -24% | -$4.06M |
|
269
Innospec
IOSP
$2.29B
| $11.4M | 0.05% |
111,652
+18,371
| +20% | +$1.92M |
|
|
SRDX
270
DELISTED
Surmodics
SRDX
| $11.4M | 0.05% |
354,738
+56,012
| +19% | +$1.9M |
|
271
AudioCodes
AUDC
$255M
| $11.2M | 0.05% |
1,106,660
+98,938
| +10% | +$1.02M |
|
|
NPKI
272
NPK International
NPKI
$1.15B
| $11.1M | 0.05% |
1,610,493
| – | – |
|
273
United Therapeutics
UTHR
$22.7B
| $11.1M | 0.05% |
49,246
-31,196
| -39% | -$7.19M |
|
274
MGIC Investment
MTG
$6.21B
| $11M | 0.05% |
661,778
+497,261
| +302% | +$8.45M |
|
275
CEMIG Preferred Shares
CIG
$5.84B
| $11M | 0.05% |
5,915,139
+2,187,107
| +59% | +$4.22M |
|
Similar funds
Acadian Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Acadian Asset Management held 1,935 positions worth $23.9B, down 1.9% from $24.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Acadian Asset Management's Q3 2023 filing shows 209 new, 532 increased, 683 reduced and 293 closed positions. Its largest new stake was Amdocs: 1,147,499 shares worth $96.9M. The largest sale was GSK, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Acadian Asset Management's largest Q3 2023 buy was Amdocs: 1,147,499 shares worth $96.9M.
- Acadian Asset Management added most to Stellantis in Q3 2023, an estimated $392M increase.
- Acadian Asset Management's biggest Q3 2023 reduction was GSK, cutting an estimated $102M.
- Acadian Asset Management fully exited KE Holdings in Q3 2023, selling an estimated $49.5M.
- Acadian Asset Management's ten largest holdings make up 21% of its $23.9B portfolio in Q3 2023.
- Acadian Asset Management opened 209 new positions and closed 293 in Q3 2023.
- Acadian Asset Management's portfolio value fell 1.9% quarter-over-quarter to $23.9B.
Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.